C26H19F3N4O2 — CID 71622802
5-[[1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-3-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one (PubChem CID 71622802) has the molecular formula C26H19F3N4O2 and a molecular weight of 476.46 g/mol. Its IUPAC name is 5-[[1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-3-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one.
| Compound Name | 5-[[1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-3-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one |
|---|---|
| PubChem CID | 71622802 |
| Molecular Formula | C26H19F3N4O2 |
| Molecular Weight | 476.46 g/mol |
| Exact Mass | 476.15 |
| IUPAC Name | 5-[[1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1,1a,6,6a-tetrahydrocyclopropa[a]inden-3-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one |
| SMILES | O=C1CCc2c(Oc3ccc4c(c3)C3C(C4)C3c3nc4ccc(C(F)(F)F)cc4[nH]3)ccnc2N1 |
| InChI | InChI=1S/C26H19F3N4O2/c27-26(28,29)13-2-5-18-19(10-13)32-25(31-18)23-17-9-12-1-3-14(11-16(12)22(17)23)35-20-7-8-30-24-15(20)4-6-21(34)33-24/h1-3,5,7-8,10-11,17,22-23H,4,6,9H2,(H,31,32)(H,30,33,34) |
| InChIKey | RBKYGVBCBBPYMX-UHFFFAOYSA-N |
| XLogP | 5.71 |
| TPSA | 79.90 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 35 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 476.46 |
| LogP ≤ 5 | 5.71 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |